Neutrolis

Neutrolis is developing first-in-class therapies for autoimmune and inflammatory diseases by targeting Neutrophil Extracellular Traps (NETs), a newly discovered innate immune pathway.

Address

Cambridge
MA
United States
Visit website (opens in a new tab)
Loading